Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV) - Image 1

Price loading...

Springer Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)

Name: Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)
Brand: Springer

Pharmacy - Dispensing

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, “drug-like” properties refer to the molecule’s physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1493950479
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 25 October 2016
Listed Since: 03 November 2016

Barcode

No barcode data available

Springer Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Optimization in Drug Discovery (Methods in Pharmacology and Toxicology)

Drug-Like Properties: Concepts, Structure Design and Methods from Adme to Toxicity Optimization

Basic Principles of Drug Discovery and Development

Drugs and a Methodological Compendium: From bench to bedside

Discovering and Developing Molecules with Optimal Drug-Like Properties: 15 (AAPS Advances in the Pharmaceutical Sciences Series, 15)

Drug Discovery and Design Using Natural Products

Optimizing the "Drug-Like" Properties of Leads in Drug Discovery: IV (Biotechnology: Pharmaceutical Aspects, IV)

Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)

Biopharmaceutics Applications in Drug Development

Fundamentals of Drug Development

Wiley - Biological Drug Products: Development and Strategies

Pharmaceutical Profiling in Drug Discovery for Lead Selection: I (Biotechnology: Pharmaceutical Aspects, I)

Drug Discovery and Development, Volume 2: Drug Development

Drug Discovery and Development (Contemporary Biomedicine)

Biopharmaceutics Applications in Drug Development

Putting Pharmacokinetics and Pharmacodynamics to Work in Drug Discovery: A Practical Guide for Pharmaceutical Scientists

Translational ADMET for Drug Therapy: Principles, Methods, and Pharmaceutical Applications

Case Studies in Modern Drug Discovery and Development

Wiley - Contemporary Accounts in Drug Discovery and Development

Drug Metabolism and Pharmacokinetics Quick Guide

Integration of Pharmaceutical Discovery and Development: Case Histories: 11 (Pharmaceutical Biotechnology, 11)

Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward

Social Aspects of Drug Discovery, Development and Commercialization

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface: 25 (AAPS Advances in the Pharmaceutical Sciences Series, 25)